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2Isotope Mixing Calculations
The isotope composition of a pool, which is formed by mixing of two separate 
reservoirs (denoted as A and B), is defined by:
∂66ZnC = (∂66ZnA x FA) + (∂66ZnB x FB) (S1)
where C denotes the mixture of the two pools, ∂66Zn is the isotopic composition of the 
reservoirs, and FX stands for the molar fraction of Zn in reservoir A or B.
As FA + FB = 1, equation S1 can be simplified to: 
∂66ZnC = (∂66ZnA x FA) + (∂66ZnB x (1– FA)) (S2)
A change or fractionation in isotopic composition is reported relative to the starting 
composition by:
Δ66Zn = ∂66ZnC – ∂66ZnA (S3)
Equations S1 and S2 can be rearranged to determine the isotopic composition that 
results for a reservoir, if some fraction of Zn with a distinct isotope composition is 
sequestered from this pool. In our case, Zn is taken up by the tumour from the blood 
(∂66Znin), sequestered within the tumour (∂66Znseq), and the tumour also expels 
residual ‘tumour-derived’ Zn (∂66Znout): 
∂66Znout = (∂66Znin – (∂66Znseq x Fseq)) / (1–Fseq) (S4)
As an additional complication, the initial uptake of Zn from blood into tumorous cells 
may occur either with or without isotope fractionation Δ66Znuptake. 
Δ66Znuptake = ∂66Znin – ∂66Znblood (S5)
If there is no isotope fractionation during Zn uptake, then Δ66Znuptake = 0, so that 
∂66Znin = ∂66Znblood ≈ +0.1 ‰.
If Zn isotope fractionation occurs during uptake, the heavy isotopes of Zn are likely 
transferred into the cells preferentially (see text), so that Δ66Znuptake > 0. This implies 
that ∂66Znin > +0.1 ‰.
3Once released, tumour-derived Zn (with ∂66Znout) is subsequently mixed with the Zn 
already present in the reservoir to which it is expelled (e.g., white blood cells, 
∂66Znres). The isotopic composition of the resulting mixture ∂66Znmix can be 
determined by applying equation S1:
∂66Znmix = (∂66Znout x Fout) + (∂66Znres x Fres) (S6)
The addition of tumour-derived Zn thus produces a change in isotope composition for 
this reservoir, denoted Δ66Znmix
Δ66Znmix = ∂66Znmix – ∂66Znres (S7)
Detection of tumour-derived Zn in this pool then requires that the change in isotopic 
composition Δ66Znmix, exceeds the precision of the analytical method. In our case, this 
analytical threshold is conservatively estimated to be ±0.20 ‰.
A plot of Δ66Znmix relative to Fout can be used to determine the minimum value of Fout 
that is required, so that the expelled ‘tumour-derived’ Zn may be detected in the 
diagnostic pool.
In our case, the mass balance of the system is only poorly constrained. Therefore, we 
calculate Δ66Znmix (using equations S4 to S7) by considering a reasonable range of 
values for (i) the fraction of Zn sequestered by the tumour, Fseq (equation S4), (ii) the 
Zn isotope fractionation Δ66Znuptake that is associated with Zn uptake by the tumour 
cells prior to sequestration (equation S5), and (iii) the initial isotope composition 
∂66Znres of the diagnostic pool (equations S6, S7). The results of these model 
calculations are summarized in Fig. S1.
In detail, the ∂66Zn for Zn in blood and sequestered in tumours is constrained by our 
analytical results (Fig. 1, main text) and values of +0.1 ‰ and –0.9 ‰, respectively, 
were used for the modelling. The isotope fractionation Δ66Znuptake for transfer of Zn 
from blood to tumour cells (before sequestration) was varied between 0 ‰ and +1 ‰. 
The (molar) fraction of Zn sequestered by the tumour (Fseq) was assumed to be 
between 40 % and 80 %. Finally, values of +0.1 ‰ (equivalent ∂66Znblood) and +1 ‰ 
were chosen for the initial isotope composition ∂66Znres of the diagnostic pool.
Depending on the combination of these factors, about 3 to 35% of the Zn in the 
diagnostic pool must be tumour-derived Zn to enable detection (Fig. S1).
4Figure S1. Estimated diagnostic sensitivity based on available isotopic 
constraints. Tumour-derived Zn is detectable in a diagnostic pool if this generates an 
isotopic difference Δ66Znmix exceeding ±0.2 ‰ (green lines). This condition is 
achieved if the (molar) fraction of tumour-derived Zn present in the diagnostic pool 
(Fout) is equivalent to about 3 to 35%.
All scenarios assume that the tumour sequesters 40 % (dotted line), 60 % (dashed 
line) or 80% (solid line) of the input Zn flux, and the sequestered Zn is characterized 
by ∂66Znseq = –0.9‰. Cases A, B and C presume that the original Zn isotope 
composition of the diagnostic pool (prior to addition of tumour-derived Zn) is 
identical to blood and serum, so that ∂66Znres = +0.1 ‰. In this case Δ66Znmix = 
∂66Znmix – 0.1 ‰ (see equation S7). No isotope fractionation occurs during Zn transfer 
to the tumour cells in Case A (Δ66Znuptake = 0; equation S5). Isotope fractionation 
during initial Zn uptake by the tumour occurs for Case B (Δ66Znuptake = +0.5 ‰) and 
C (Δ66Znuptake = +1 ‰). Case D assumes ∂66Znres = +1 ‰, and Δ66Znuptake = +0.5 ‰.
